Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-20
2008-05-20
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S453000
Reexamination Certificate
active
07375128
ABSTRACT:
The present invention relates to a compound of formula (I): wherein R is hydrogen atom, hydroxyl group or carbamoyl group, and n is 1 or 2, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: A-82875/87 (1988-06-01), None
patent: WO 98/39303 (1998-09-01), None
patent: WO 98/58947 (1998-12-01), None
patent: WO-01/30781 (2001-05-01), None
Accession No. 2005:24021, CAPLUS abstract of JP 2005068145, Sircar, Ila et al, “Pharmaceutical compositions containing 1,3-diazobicyclo[3.3.0]octane-2,4-dione derivatives for prevention and treatment of LFA-1 (integrin aLb2)-mediated diseases.”
Bochner, B.S., “Adhesion Molecules in Allergic Disease” Marcel Decker, Inc., pp. 1-24. 1997.
Gahmberg, C.G., “Leukocyte Adhesion: CD11/CD18 Integrins and Intercellular Adhesion Molecules”, Curr Opin Cell Biol., pp. 643-650, Oct. 1997..
Panes J., et al., “Leukocyte-Endothelial Cell Adhesion:Avenues for Therapeutic Intervention”, Br J. Pharmacol, pp. 537-550, Feb. 1999.
Dustin, M.L., et al., “Induction by IL 1 and Interferon-Gamma: Tissue Distribution, Biochemistry, and Function of a Natural Adherence Molecule (ICAM-1)”, J. Immunol, pp. 245-254, Jul. 1, 1986.
Wingren, A.G., et al., “T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T cell Profiles”, Crit. Rev. Immunol., pp. 235-253, 1995.
Kaji Hidefumi
Kakushima Masatoshi
Kawaguchi Takayuki
Kume Toshiyuki
Morningstar Marshall
Birch & Stewart Kolasch & Birch, LLP
Coppins Janet L
Mitsubishi Tanabe Pharma Corporation
Saeed Kamal A.
LandOfFree
Inhibitors of α 1 β 2 integrin mediated cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of α 1 β 2 integrin mediated cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of α 1 β 2 integrin mediated cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2759168